Kelly Financial Services’s MediciNova MNOV Stock Holding History

Kelly Financial Services’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$505	–	655
2021 Q1	$505	Buy	+100	New	+$582	﹤0.01%	583

Other funds holding MNOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kelly Financial Services's MNOV Position: Q2 2021 in Review

Kelly Financial Services sold out of MediciNova (MNOV) in Q2 2021, closing a stake of 100 shares — an estimated $505 sold.

Kelly Financial Services first reported a position in MNOV in Q1 2021 and held it in 1 quarter. The position peaked at $505 in Q1 2021. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2021.

Kelly Financial Services reported no remaining MediciNova position as of Q2 2021 after selling out during the quarter.
Kelly Financial Services sold 100 MediciNova shares in Q2 2021, an estimated $505.
Kelly Financial Services first reported a position in MediciNova in Q1 2021 and held it in 1 quarter.
Kelly Financial Services's MediciNova position peaked at $505 in Q1 2021.
55 funds tracked by Wall St. Rank held MediciNova as of Q2 2021.

Based on Kelly Financial Services's 13F filing for Q2 2021, filed 17 Jul 2024.